Licayan, Liza .
HRN: 22-16-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CEFUROXIME 500MG (TAB)
09/27/2023
10/04/2023
PO
500mg
BID
SP NSVD W RMLE AND REPAIR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes